Fresenius | FRE - Net Income

Stock Price
47.96
Daily Change
0.75 1.59%
Monthly
0.57%
Yearly
28.99%
Q1 Forecast
45.82

Fresenius reported EUR344M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Akzo Nobel EUR -194M 318M Sep/2025
Alcon AG USD 237M 61M Sep/2025
AstraZeneca USD 2.53B 83M Sep/2025
BASF EUR 172M 93M Sep/2025
Bayer EUR -963M 764M Sep/2025
Beiersdorf EUR 552M 222M Jun/2025
DaVita Healthcare Partners USD 150.33M 49M Sep/2025
Demant DKK 1.12B 71M Jun/2025
E.ON EUR -51M 491M Sep/2025
Essilor EUR 1.39B 890M Jun/2025
Fresenius EUR 344M 14M Sep/2025
Fresenius Medical Care EUR 274.8M 49.8M Sep/2025
Getinge SEK 662M 661M Dec/2024
Givaudan CHF 294M 150M Jun/2024
GlaxoSmithKline GBP 2.01B 570M Sep/2025
GN Store Nord DKK 73M 92M Sep/2025
GRIFOLS EUR 126.96M 9.9M Sep/2025
Hikma Pharmaceutical USD 119M 14M Jun/2025
Lonza CHF 307M 22M Dec/2024
Merck EUR 902M 250M Sep/2025
Novartis USD 3.93B 96M Sep/2025
Philips EUR 184M 56M Sep/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
RWE EUR 846M 183M Sep/2025
Sanofi EUR -801M 3.6B Dec/2025
Smith & Nephew USD 293M 79M Dec/2025